The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

The research focus on improving non-motor symptoms in PD patients is also highlighted. (Image Credits: Pixabay) Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving ...

A common and widely used chemical may be fueling the rise of the world's fastest-growing brain condition – Parkinson's disease. For the past 100 years, trichloroethylene (TCE) has been used to ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Smartwatches gather vast amounts of data about our physiology. Now their technology is being harnessed like never before.

A national Parkinson’s disease charity is offering up to £3,000 in grant funding for any communities with a connection to the condition across Cumbria.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...